Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to year 1
Awards & highlights
Summary
The purpose of this study is to continuously assess the visual performance and safety of DAILIES TOTAL1 soft contact lenses in a real world setting and broader patient base through routine clinical practices. This activity will be used to continuously support delefilcon A (sphere, toric, and multifocal) soft contact lens regulatory requirements and standards.
Eligible Conditions
- Presbyopia
- Astigmatism
- Near-sightedness
- Farsightedness
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to year 1
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to year 1
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Distance visual acuity (VA) with study lenses at Baseline - Sphere and Toric
Distance visual acuity with study lenses at Baseline - Multifocal
Distance visual acuity with study lenses at Year 1 Follow-Up - Multifocal
+5 moreTrial Design
3Treatment groups
Experimental Treatment
Group I: DAILIES TOTAL1 ToricExperimental Treatment1 Intervention
Delefilcon A toric soft contact lenses worn in both eyes in a real-world setting
Group II: DAILIES TOTAL1 SphereExperimental Treatment1 Intervention
Delefilcon A spherical soft contact lenses worn in both eyes in a real-world setting
Group III: DAILIES TOTAL1 MultifocalExperimental Treatment1 Intervention
Delefilcon A multifocal soft contact lenses worn in both eyes in a real-world setting
Find a Location
Who is running the clinical trial?
Alcon ResearchLead Sponsor
724 Previous Clinical Trials
128,129 Total Patients Enrolled
36 Trials studying Presbyopia
6,274 Patients Enrolled for Presbyopia
Clinical Trial Lead, Vision CareStudy DirectorAlcon Research, LLC
24 Previous Clinical Trials
4,336 Total Patients Enrolled
3 Trials studying Presbyopia
327 Patients Enrolled for Presbyopia
Share this study with friends
Copy Link
Messenger